ANDA 76806, held by Dr Reddys. Deferoxamine Mesylate.
As of Nov 15, 2026, ANDA 76806 (Deferoxamine Mesylate), held by Dr Reddys, was first approved by FDA on Mar 31, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 2006 | Original application | Approved | None posted |
| Deferoxamine Mesylate500MG/VIAL · injectable;injection | Deferoxamine Mesylate | Discontinued |
| Deferoxamine Mesylate2GM/VIAL · injectable;injection | Deferoxamine Mesylate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
